Modification Agreements in the Biotechnology Industry

1,866 Contracts & Agreements

Browse by Company

89bio, Inc. (1 contract)
AbbVie Inc. (5)
ABEONA THERAPEUTICS INC. (1)
ACADIA PHARMACEUTICALS INC (5)
Achaogen, Inc. (20)
ACHIEVE LIFE SCIENCES, INC. (3)
Acorda Therapeutics (9)
Actinium Pharmaceuticals, Inc. (1)
Adaptimmune Therapeutics PLC (6)
Adhera Therapeutics, Inc. (17)
ADiTx Therapeutics, Inc. (9)
ADMA BIOLOGICS, INC. (4)
ADURO BIOTECH, INC. (2)
Advaxis, Inc. (1)
Adverum Biotechnologies, Inc. (1)
Aeglea BioTherapeutics, Inc. (1)
Aerovate Therapeutics, Inc. (1)
AGENUS INC (9)
AgeX Therapeutics, Inc. (3)
AILERON THERAPEUTICS INC (2)
Akebia Therapeutics, Inc. (6)
ALBIREO PHARMA, INC. (1)
Aldeyra Therapeutics, Inc. (2)
Alexion Pharmaceuticals (7)
Alkermes plc. (1)
Allarity Therapeutics, Inc. (4)
Alliqua BioMedical, Inc. (1)
ALNYLAM PHARMACEUTICALS, INC. (5)
ALPINE IMMUNE SCIENCES, INC. (1)
Altimmune, Inc. (10)
AMARILLO BIOSCIENCES INC (2)
AMARIN CORP PLC (2)
Amgen Inc. (10)
AMICUS THERAPEUTICS, INC. (3)
AmpliPhi Biosciences Corp (11)
Amplitude Healthcare Acquisition Corp (1)
ANAVEX LIFE SCIENCES CORP. (1)
Anika Therapeutics (2)
Anixa Biosciences Inc (3)
Applied Molecular Transport Inc. (1)
Aptevo Therapeutics Inc. (7)
AQUINOX PHARMACEUTICALS, INC (2)
Aravive, Inc. (2)
Arbutus Biopharma Corp (40)
ARCA biopharma, Inc. (20)
Arcturus Therapeutics Holdings Inc. (3)
Arcus Biosciences, Inc. (1)
ARDELYX, INC. (5)
ARENA PHARMACEUTICALS INC (7)
ARROWHEAD PHARMACEUTICALS, INC. (1)
Arsanis, Inc. (4)
Artiva Biotherapeutics, Inc. (3)
ASSEMBLY BIOSCIENCES, INC. (2)
Atara Biotherapeutics, Inc. (4)
Athenex, Inc. (9)
ATHERSYS, INC (3)
ATOSSA GENETICS INC (1)
Atreca, Inc. (1)
aTYR PHARMA INC (2)
Avid Bioservices, Inc. (1)
Avita Therapeutics, Inc. (4)
Axcella Health Inc. (3)
Axovant Sciences Ltd. (1)
AZIYO BIOLOGICS, INC. (6)
AzurRx BioPharma, Inc. (3)
Beam Therapeutics Inc. (1)
BELLICUM PHARMACEUTICALS, INC (4)
BICYCLE THERAPEUTICS Ltd (5)
BioCardia, Inc. (1)
BIOCEPT INC (6)
BIOCRYST PHARMACEUTICALS INC (22)
Biogen Inc. (11)
BioLife4D Corp (1)
BIOMARIN PHARMACEUTICAL INC (3)
BioRestorative Therapies, Inc. (16)
BIOSPECIFICS TECHNOLOGIES CORP (7)
BIOTIME INC (5)
BIOVIE INC. (3)
BioXcel Therapeutics, Inc. (2)
BIOXYTRAN, INC (6)
Blue Water Vaccines Inc. (4)
bluebird bio, Inc. (5)
Blueprint Medicines Corp (3)
Bone Biologics Corp (2)
BRAINSTORM CELL THERAPEUTICS INC. (5)
BridgeBio Pharma, Inc. (3)
Cabaletta Bio, Inc. (4)
CALADRIUS BIOSCIENCES, INC. (9)
Calyxt, Inc. (1)
CANCER GENETICS, INC (12)
Candel Therapeutics, Inc. (1)
CAPRICOR THERAPEUTICS, INC. (2)
CAPSTAR SPECIAL PURPOSE ACQUISITION CORP. (2)
Capstone Therapeutics Corp. (16)
CareDx, Inc. (3)
Caribou Biosciences, Inc. (2)
CASI Pharmaceuticals, Inc. (2)
CASTLE BIOSCIENCES INC (5)
CATALYST BIOSCIENCES, INC. (6)
CATALYST PHARMACEUTICALS, INC. (2)
CEL SCI CORP (1)
Celcuity Inc. (1)
Cell Source, Inc. (7)
Celldex Therapeutics, Inc. (5)
Cellectar Biosciences, Inc. (2)
Cellular Biomedicine Group, Inc. (1)
Celsion CORP (6)
Centessa Pharmaceuticals Ltd (1)
Century Therapeutics, Inc. (2)
CEREBAIN BIOTECH CORP. (2)
Chanticleer Holdings, Inc. (2)
Chardan Healthcare Acquisition 2 Corp. (1)
Chardan Healthcare Acquisition Corp. (1)
Checkpoint Therapeutics, Inc. (5)
Chelsea Worldwide Inc. (3)
ChemoCentryx, Inc. (2)
CHIMERIX INC (51)
CLEVELAND BIOLABS INC (10)
CM Life Sciences III Inc. (1)
Coherus BioSciences, Inc. (4)
COMPASS Pathways plc (1)
Conatus Pharmaceuticals Inc. (1)
CONCERT PHARMACEUTICALS, INC. (1)
Consonance-HFW Acquisition Corp. (1)
Constellation Alpha Capital Corp. (1)
CONTRAFECT Corp (2)
Corvus Pharmaceuticals, Inc. (2)
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (10)
CTD HOLDINGS INC (2)
CTI BIOPHARMA CORP (12)
Cue Biopharma, Inc. (2)
Curative Biotechnology Inc (19)
CURIS INC (2)
Cyclacel Pharmaceuticals, Inc. (9)
CytoDyn Inc. (7)
Cytokinetics, Incorporated (9)
CytomX Therapeutics, Inc. (1)
CYTORI THERAPEUTICS, INC. (17)
CYTRX CORP (6)
Denali Therapeutics Inc. (1)
Diffusion Pharmaceuticals Inc. (3)
Dynamics Special Purpose Corp. (1)
DYNAVAX TECHNOLOGIES CORP (11)
Eagle Pharmaceuticals, Inc. (1)
Edge Therapeutics, Inc. (2)
Editas Medicine, Inc. (3)
Eidos Therapeutics, Inc. (1)
Eiger BioPharmaceuticals, Inc. (2)
Emerald Bioscience, Inc. (7)
Emergent BioSolutions Inc. (48)
Enanta Pharmaceuticals, Inc. (2)
ENDONOVO THERAPEUTICS, INC. (1)
Enochian Biosciences Inc (1)
ENZON PHARMACEUTICALS, INC. (8)
Epizyme, Inc. (3)
Equillium, Inc. (5)
Esperion Therapeutics, Inc. (3)
Evelo Biosciences, Inc. (3)
EXACT SCIENCES CORP (7)
Exelixis (8)
EXICURE, INC. (2)
FENNEC PHARMACEUTICALS INC. (1)
Fibrocell Science, Inc. (1)
Finch Therapeutics Group, Inc. (3)
FIVE PRIME THERAPEUTICS INC (2)
Flex Pharma, Inc. (3)
Flexion Therapeutics Inc (4)
FLUOROPHARMA MEDICAL, INC. (2)
Foghorn Therapeutics Inc. (1)
Fortress Biotech, Inc. (1)
FS Development Corp. (2)
Fusion Pharmaceuticals Inc. (2)
G1 Therapeutics, Inc. (1)
GALECTIN THERAPEUTICS INC (6)
Gemphire Therapeutics Inc. (1)
Gene Biotherapeutics, Inc. (6)
GENEREX BIOTECHNOLOGY CORP (19)
GENOCEA BIOSCIENCES, INC. (2)
Genprex, Inc. (2)
GeoVax Labs, Inc. (6)
GERON CORP (2)
Gilead Sciences (5)
Gossamer Bio, Inc. (1)
Greater Cannabis Company, Inc. (1)
Gritstone Oncology, Inc. (2)
GT Biopharma, Inc. (6)
GTX INC (1)
GX Acquisition Corp. (3)
HALOZYME THERAPEUTICS INC (4)
HARBOR DIVERSIFIED, INC. (8)
Harpoon Therapeutics, Inc. (3)
HEAT BIOLOGICS, INC. (11)
HedgePath Pharmaceuticals, Inc. (4)
HEMISPHERX BIOPHARMA INC (19)
HERON THERAPEUTICS, INC. (2)
HilleVax, Inc. (1)
HISTOGENICS CORP (4)
Homology Medicines, Inc. (3)
HOOKIPA Pharma Inc. (1)
HUMANIGEN, INC (5)
IDEAYA Biosciences, Inc. (5)
IDERA PHARMACEUTICALS, INC. (5)
IMMUCELL CORP (9)
IMMUNE PHARMACEUTICALS INC (12)
ImmunoCellular Therapeutics, Ltd. (1)
IMMUNOGEN INC (3)
Immunome Inc. (3)
IMMUNOMEDICS INC (1)
IMPEL NEUROPHARMA INC (1)
IN8BIO, INC. (1)
Incyte (2)
INFINITY PHARMACEUTICALS, INC. (6)
Inhibikase Therapeutics, Inc. (1)
Inhibrx, Inc. (7)
InMed Pharmaceuticals Inc. (1)
Inmune Bio, Inc. (5)
INOVIO PHARMACEUTICALS, INC. (1)
Inozyme Pharma, Inc. (1)
INSMED Inc (11)
Inspyr Therapeutics, Inc. (1)
Intellia Therapeutics, Inc. (1)
INTERCEPT PHARMACEUTICALS, INC. (6)
International Stem Cell CORP (2)
INTREXON CORP (2)
Intrinsic Medicine, Inc. (1)
Invitae Corp (1)
IONIS PHARMACEUTICALS INC (8)
IOVANCE BIOTHERAPEUTICS, INC. (5)
IRONWOOD PHARMACEUTICALS INC (1)
Isoray, Inc. (7)
KalVista Pharmaceuticals, Inc. (3)
Karyopharm Therapeutics Inc. (1)
KBL MERGER CORP. IV (4)
Kindred Biosciences, Inc. (5)
Kiromic Biopharma, Inc. (1)
Kodiak Sciences Inc. (1)
Krystal Biotech, Inc. (1)
Kura Oncology, Inc. (3)
LA JOLLA PHARMACEUTICAL CO (6)
Leisure Acquisition Corp. (11)
LEXICON PHARMACEUTICALS, INC. (10)
LianBio (1)
Ligand Pharmaceuticals Incorporated (18)
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (1)
Locust Walk Acquisition Corp. (1)
LogicBio Therapeutics, Inc. (5)
Lyell Immunopharma, Inc. (1)
MACROGENICS INC (1)
MADRIGAL PHARMACEUTICALS, INC. (3)
Magenta Therapeutics, Inc. (1)
MANHATTAN SCIENTIFICS INC (1)
MANNKIND CORP (5)
MARIZYME INC (4)
Marker Therapeutics, Inc. (4)
MATEON THERAPEUTICS INC (3)
Medovex Corp. (4)
MEI Pharma, Inc. (3)
MeiraGTx Holdings plc (1)
MERRIMACK PHARMACEUTICALS INC (5)
Mersana Therapeutics, Inc. (2)
Millendo Therapeutics, Inc. (4)
MiMedx Group, Inc. (3)
Minerva Neurosciences, Inc. (1)
MIRAGEN THERAPEUTICS, INC. (6)
Moderna, Inc. (11)
Molecular Templates, Inc. (4)
Momenta Pharmaceuticals, Inc. (5)
MUSTANG BIO, INC. (1)
MYMETICS CORP (1)
Myovant Sciences Ltd. (4)
Myriad Genetics, Inc. (2)
NANOVIRICIDES, INC. (3)
NantKwest, Inc. (8)
Natera, Inc. (3)
NAVIDEA BIOPHARMACEUTICALS, INC. (6)
NEUROBIOLOGICAL TECHNOLOGIES INC (3)
NEUROCRINE BIOSCIENCES INC (2)
NEUROTROPE BIOSCIENCE, INC. (1)
Neurotrope, Inc. (3)
NEWLINK GENETICS CORP (26)
NextCure, Inc. (2)
NORTHWEST BIOTHERAPEUTICS INC (27)
NOVAVAX INC (29)
Novus Therapeutics, Inc. (3)
NTN BUZZTIME INC (8)
Nuo Therapeutics, Inc. (6)
Olema Pharmaceuticals, Inc. (1)
Olivia Ventures, Inc. (2)
OncBioMune Pharmaceuticals, Inc (4)
OncoCyte Corp (2)
ONCOSEC MEDICAL Inc (3)
OPGEN INC (3)
Ophthotech Corp. (3)
Opko Health, Inc. (1)
ORAGENICS INC (1)
Orchard Therapeutics plc (1)
Organogenesis Holdings Inc. (3)
ORGANOVO HOLDINGS, INC. (1)
Orgenesis Inc. (4)
Outlook Therapeutics, Inc. (6)
Passage BIO, Inc. (2)
PDL BIOPHARMA, INC. (5)
Pfenex Inc. (20)
PharmaCyte Biotech, Inc. (3)
PhaseBio Pharmaceuticals Inc (2)
Phio Pharmaceuticals Corp. (9)
PIERIS PHARMACEUTICALS, INC. (3)
PLURISTEM THERAPEUTICS INC (3)
POLARITYTE, INC. (10)
PORTOLA PHARMACEUTICALS INC (1)
PRECISION BIOSCIENCES INC (5)
PREMIER BIOMEDICAL INC (2)
Progenics Pharmaceuticals, Inc. (2)
PROGENITY, INC. (5)
ProMIS Neurosciences Inc. (2)
Propanc Biopharma, Inc. (5)
Protagenic Therapeutics, Inc. (8)
Protagonist Therapeutics, Inc (2)
Protalix BioTherapeutics, Inc. (1)
PROTEON THERAPEUTICS INC (1)
PROTEOSTASIS THERAPEUTICS, INC. (6)
Prothena Corp plc (2)
PTC THERAPEUTICS, INC. (2)
PUMA BIOTECHNOLOGY, INC. (5)
Pyxis Oncology, Inc. (1)
Q BioMed Inc. (4)
Qrons Inc. (4)
Radius Health, Inc. (7)
RAPT Therapeutics, Inc. (2)
RECURSION PHARMACEUTICALS, INC. (1)
Regeneron Pharmaceuticals (22)
Regulus Therapeutics Inc. (4)
RenovaCare, Inc. (3)
Replimune Group, Inc. (1)
Retrophin, Inc. (1)
REXAHN PHARMACEUTICALS, INC. (3)
RIGEL PHARMACEUTICALS INC (3)
RITTER PHARMACEUTICALS INC (8)
Rubius Therapeutics, Inc. (1)
Sage Therapeutics, Inc. (1)
SANGAMO THERAPEUTICS, INC (3)
Sarepta Therapeutics, Inc. (13)
Savara Inc (6)
Scholar Rock Holding Corp (1)
SEATTLE GENETICS INC (1)
SELECTA BIOSCIENCES INC (3)
SELLAS Life Sciences Group, Inc. (11)
SERA PROGNOSTICS, INC. (1)
Seres Therapeutics, Inc. (1)
Sesen Bio, Inc. (4)
Shuttle Pharmaceuticals Holdings, Inc. (7)
Silverback Therapeutics, Inc. (1)
SOLENO THERAPEUTICS INC (4)
SOLIGENIX, INC. (3)
SOPHIRIS BIO INC. (1)
Sorrento Therapeutics, Inc. (8)
Spectrum Pharmaceuticals, Inc. (6)
SPHERIX INC (6)
Spring Bank Pharmaceuticals, Inc. (2)
SPRUCE BIOSCIENCES, INC. (2)
Summit Therapeutics Inc. (1)
Sun BioPharma, Inc. (3)
SUNESIS PHARMACEUTICALS INC (4)
Surface Oncology, Inc. (1)
SUTRO BIOPHARMA, INC. (6)
Syndax Pharmaceuticals Inc (14)
SYNLOGIC, INC. (4)
Synthetic Biologics, Inc. (2)
Syros Pharmaceuticals, Inc. (2)
T2 Biosystems, Inc. (16)
TENAX THERAPEUTICS, INC. (2)
TG THERAPEUTICS, INC. (4)
Tocagen Inc (4)
Tonix Pharmaceuticals Holding Corp. (3)
Tracon Pharmaceuticals, Inc. (3)
Translate Bio, Inc. (1)
TREVENA INC (3)
Trovagene, Inc. (1)
TYME TECHNOLOGIES, INC. (2)
Ultragenyx Pharmaceutical Inc. (2)
Unicycive Therapeutics, Inc. (1)
uniQure N.V. (1)
United Therapeutics Corp (13)
Unity Biotechnology, Inc. (2)
UroGen Pharma Ltd. (1)
VACCINEX, INC. (3)
Vanda Pharmaceuticals Inc. (4)
Vaxart, Inc. (8)
Vaxcyte, Inc. (1)
VBI Vaccines Inc (14)
Vera Therapeutics, Inc. (1)
VERACYTE, INC. (1)
Verastem, Inc. (2)
Vericel Corp (11)
VICAL INC (5)
Vicapsys Life Sciences, Inc. (2)
Viela Bio, Inc. (1)
Vir Biotechnology, Inc. (8)
VistaGen Therapeutics, Inc. (5)
VITAL THERAPIES INC (3)
VITRO DIAGNOSTICS INC (2)
vTv Therapeutics Inc. (4)
WINDTREE THERAPEUTICS INC (7)
Xencor Inc (2)
Xenetic Biosciences, Inc. (5)
Xenon Pharmaceuticals Inc. (1)
XOMA Corp (9)
YIELD10 BIOSCIENCE, INC. (2)
ZAFGEN, INC. (1)
ZIOPHARM ONCOLOGY INC (4)
Zymeworks Inc. (1)

Recent Contracts

Category

Company

Industry

Jur. Jurisdiction

Filed

Amendment to Rescission Agreement among Entero Therapeutics Inc., ImmunogenX, LLC, and Former Shareholders of ImmunogenX, Inc.

Modification Agreements

AzurRx BioPharma, Inc.

Biotechnology

2025

Onconetix and Series C Convertible Preferred Stockholder Conversion Price Reduction Consent Agreement

Modification Agreements

Blue Water Vaccines Inc.

Biotechnology

2025

Fifth Amendment to Loan and Security Agreement among SLR Investment Corp., Lenders, and Ardelyx, Inc.

Modification Agreements

ARDELYX, INC.

Biotechnology

2025

Amendment No. 5 to Brainstorm Cell Therapeutics Inc. 2014 Global Share Option Plan

Modification Agreements

BRAINSTORM CELL THERAPEUTICS INC.

Biotechnology

2025

Amendment and Termination Agreement between Plus Therapeutics, Inc. and Investors (June 17, 2025)

Modification Agreements

CYTORI THERAPEUTICS, INC.

Biotechnology

2025

Amendment to Third Amended and Restated PDS Biotechnology Corporation 2014 Equity Incentive Plan

Modification Agreements

Edge Therapeutics, Inc.

Biotechnology

2025

Amendment to Securities Purchase Agreement and Warrants between Synaptogenix, Inc. and Investors (June 2025)

Modification Agreements

NEUROTROPE BIOSCIENCE, INC.

Biotechnology

2025

Letter Agreement Regarding Wind-Down of HIV Trial and Amendment to Collaboration Agreement between Gilead Sciences, Inc. and Hookipa Biotech GmbH

Modification Agreements

HOOKIPA Pharma Inc.

Biotechnology

2025

Amendment to Amended and Restated Commercialization Agreement between Atara Biotherapeutics, Inc. and Pierre Fabre Medicament (March 31, 2025)

Modification Agreements

Atara Biotherapeutics, Inc.

Biotechnology

2025

First Amendment to Transition Services Agreement between Passage Bio, Inc. and Gemma Biotherapeutics, Inc.

Modification Agreements

Passage BIO, Inc.

Biotechnology

2025

Amendment to Securities Purchase Agreement between Pluri Inc. and Chutzpah Holdings Limited (April 25, 2025)

Modification Agreements

PLURISTEM THERAPEUTICS INC

Biotechnology

NY

2025

Amendment to Rescission Agreement among Entero Therapeutics Inc., ImmunogenX, LLC, and Former Shareholders of ImmunogenX, Inc.

Modification Agreements

AzurRx BioPharma, Inc.

Biotechnology

NY

2025

Maturity Extension Agreement between Propanc Biopharma Inc. and Ionic Ventures, LLC (May 2025)

Modification Agreements

Propanc Biopharma, Inc.

Biotechnology

2025

Amendment No. 1 to Securities Purchase Agreement by and among IN8bio, Inc. and Certain Investors

Modification Agreements

IN8BIO, INC.

Biotechnology

2025

Amendment to Securities Purchase Agreement between Pluri Inc. and Chutzpah Holdings Limited (April 25, 2025)

Modification Agreements

PLURISTEM THERAPEUTICS INC

Biotechnology

NY

2025

Second Amendment to Grant Agreement between Gates Foundation and Decoy Therapeutics, Inc. (INV-027470)

Modification Agreements

Flex Pharma, Inc.

Biotechnology

2025

Amendment to July 17, 2023 Letter Agreement between Neurogene Inc. and Baker Bros. Advisors LP

Modification Agreements

AQUINOX PHARMACEUTICALS, INC

Biotechnology

2025

Third Amendment to Section 382 Rights Agreement between Enzon Pharmaceuticals, Inc. and Continental Stock Transfer & Trust Company

Modification Agreements

ENZON PHARMACEUTICALS, INC.

Biotechnology

DE

2025

Modification No. 04 to RRPV Project Award No. 01 between Vaxart Biosciences Inc. and Advanced Technology International

Modification Agreements

Vaxart, Inc.

Biotechnology

2025

Amendment to Stock Option Agreement between Eledon Pharmaceuticals, Inc. and Employee

Modification Agreements

Novus Therapeutics, Inc.

Biotechnology

2025

Amendment to Stock Option Agreement between Eledon Pharmaceuticals, Inc. and [NAME]

Modification Agreements

Novus Therapeutics, Inc.

Biotechnology

2025

First Amendment to Research Funding and Option Agreement between Xenetic Biosciences Inc. and The Scripps Research Institute

Modification Agreements

Xenetic Biosciences, Inc.

Biotechnology

2025

Third Amendment to Credit and Security Agreement between Armata Pharmaceuticals, Inc. and Innoviva Strategic Opportunities LLC

Modification Agreements

AmpliPhi Biosciences Corp

Biotechnology

NY

2025

First Amendment to Credit and Security Agreement between Armata Pharmaceuticals, Inc. and Innoviva Strategic Opportunities LLC

Modification Agreements

AmpliPhi Biosciences Corp

Biotechnology

NY

2025

Sixth Amendment to Corporate Sponsored Research Agreement between Inozyme Pharma, Inc. and Yale University

Modification Agreements

Inozyme Pharma, Inc.

Biotechnology

2025

Extension Agreement Amending Letter Agreement for Merger Between Predictive Oncology, Inc. and Renovaro, Inc.

Modification Agreements

Enochian Biosciences Inc

Biotechnology

2025

First Amendment to Securities Purchase and Exchange Agreement between Plus Therapeutics, Inc. and Purchasers

Modification Agreements

CYTORI THERAPEUTICS, INC.

Biotechnology

2025

Amendment to Exclusive Option Agreement between Aldeyra Therapeutics, Inc. and AbbVie, Inc. regarding Reproxalap Commercialization

Modification Agreements

Aldeyra Therapeutics, Inc.

Biotechnology

2025

Amendment Agreement to Securities Purchase Agreement among Shuttle Pharmaceuticals Holdings, Inc., Alto Opportunity Master Fund, and Guarantors

Modification Agreements

Shuttle Pharmaceuticals Holdings, Inc.

Biotechnology

2025

Fifth Amendment to Loan and Security Agreement among Bluebird Bio, Inc., Hercules Capital, Inc., and Lenders

Modification Agreements

bluebird bio, Inc.

Biotechnology

CA

2025

First Amendment to Revenue Interest Purchase Agreement between Insmed Incorporated and OrbiMed Royalty & Credit Opportunities IV, LP

Modification Agreements

INSMED Inc

Biotechnology

NY

2025

Amendment No. 5 to Clinical Trial Collaboration and Supply Agreement between Pfizer Inc. and Ideaya Biosciences, Inc.

Modification Agreements

IDEAYA Biosciences, Inc.

Biotechnology

2025

Modification No. 05 to RRPV Project Award No. 01 between Vaxart Biosciences Inc. and Advanced Technology International

Modification Agreements

Vaxart, Inc.

Biotechnology

2025

Amendment to Warrant Exchange Agreement between Cyclacel Pharmaceuticals, Inc. and Armistice Capital Master Fund Ltd.

Modification Agreements

Cyclacel Pharmaceuticals, Inc.

Biotechnology

NY

2025

Amendment Agreement to License and Collaboration Agreement between Regeneron Pharmaceuticals, Inc. and Bayer Healthcare LLC (May 7, 2012)

Modification Agreements

Regeneron Pharmaceuticals

Biotechnology

2025

Second Amendment to Debt Modification Agreement between Bioxytran, Inc. and Walleye Opportunities Master Fund Ltd.

Modification Agreements

BIOXYTRAN, INC

Biotechnology

2025

Amendment to Debt Modification Agreement between Bioxytran, Inc. and Walleye Opportunities Master Fund Ltd (July 25, 2024)

Modification Agreements

BIOXYTRAN, INC

Biotechnology

2025

First Amendment to At Market Issuance Sales Agreement between Protagenic Therapeutics, Inc. and B. Riley Securities, Inc.

Modification Agreements

Protagenic Therapeutics, Inc.

Biotechnology

2025

Amendment to Term Sheet Between Mosaic ImmunoEngineering, Inc. and Oncotelic Therapeutics, Inc. Extending Expiration Date

Modification Agreements

MATEON THERAPEUTICS INC

Biotechnology

2025

Third Amendment to Revolving Credit, Term Loan and Security Agreement among TotalStone, LLC, Northeast Masonry Distributors, LLC, and Berkshire Bank

Modification Agreements

Capstone Therapeutics Corp.

Biotechnology

2024